Revenue growth to be achieved at listed Kromek

Listed radiation detection technology company, Kromek, which has its research base in Huddersfield, has this morning said it is in line to achieve revenue growth for the full year 2018/19 and EBITDA profit in-line with market expectations. 

Publishing a trading updated for the year ended 30 April 2019, the firm said it had “entered the second half of 2018/19 in a stronger position than at the same point of the prior year with the Company delivering on its previously-signed customer product contracts in all of its segments as well as continuing to win new orders. This progress continued throughout the period.” 

Kromek added that it continued to gain traction in all its business segments with the award of high-value, multi-year contracts from its commercial and large government customers worldwide.

Kromek said: “With the increasing market adoption of its customers’ next-generation products that incorporate Kromek’s radiation detection solutions, combined with the successful fundraising completed in the second half of 2018/19, the Company is well-placed to capitalise on the expanding opportunities. Consequently, the Board continues to look to the future with confidence.”